Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer

Bayrak M., Olmez O. F., Kurt E., ÇUBUKÇU E., EVRENSEL T., Kanat O., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, sa.4, ss.307-312, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s12094-012-0921-0
  • Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.307-312
  • Anahtar Kelimeler: c-erbB2, Gastric cancer, Metastasis, Immunohistochemistry, Prognosis, EXPRESSION, TRASTUZUMAB, BREAST, HER2
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Overexpression of the gene c-erbB2, which encodes a receptor tyrosine kinase, has been associated with prognosis and response to therapy in several solid tumors. This study was designed to test whether c-erb-B2 overexpression can be related to prognosis of patients with metastatic gastric cancer.